On Nov 3, 2021, Mindray was awarded the second prize of the 2020 China National Science and Technology Awards for Invention, for the fluorescent dyes in hematology analysis we co-developed with Dalian University of Technology.
Mindray and Dalian University of Technology have worked together to solve complex technical problems encountered in hematology analysis. Focusing on the relationship between molecular structure and the performance of targeted fluorescent dyes, the two parties developed a new fluorescent dye design, innovating the concept principle, and targeting function expansion and industrial application. The collaboration led to the successful development of advanced targeted fluorescent dyes with a patent.
The patented fluorescent dyes are adopted for the SF Cube 3D analysis technology on Mindray high-end hematology analyzers including BC-6800Plus and BC-6000 Series. SF Cube is an innovative technology of blood cell analysis for Reticulocytes, NRBCs and WBC 5-Diff counts, with effective flagging of abnormal cells such as Atypical Lymphocytes and Blast Cells, as well as RBC Fragments and Lipid Particles.
Based on this patented fluorescent dye technology, Mindray continues to innovate and has achieved many breakthroughs in this field, developing a series of high-end hematology systems over the years.
Along the path of transforming advanced technology into reliable laboratory solutions, Mindray received many honors and recognitions. In 2008, the company won the second prize in the National Science and Technology Progress Awards with its R&D and industrialization of key technologies, and the development of a series of high performance auto biochemistry analyzers. In the 2017 National Technology Invention Awards, Mindray was awarded the second prize for the "Key Technologies and Applications of Ultrasonic Shear Wave Elastography" project it co-developed with Shenzhen Institute of Advanced Technology Chinese Academy of Sciences.
Each award is an affirmation of Mindray’s commitment to R&D and innovation. Mindray consistently invests in research and development, as well as continuous innovation for the improvement of core technologies, which in turn, promote innovation and further development in the medical industry. Mindray will continue to provide innovative, reliable laboratory solutions to improve the efficiency of clinical diagnosis and promote the development of frontier research in laboratory medicine.
